Trial ID 18194 | Maryland Oncology Hematology Trial ID 18194 – Maryland Oncology Hematology

Trial ID 18194

Trial Information - Phase I

A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an anti-Folate Receptor alpha (FolRá) Antibody Drug Conjugate (ADC), in Patients with Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers

Protocol ID: STRO-002-GM1

Sponsor: Chiltern International/ Sutro Biopharma

Status: STUDY ON HOLD

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Ovarian

Investigator

Aylesworth MD, Cheryl

Status

STUDY ON HOLD

Sponsor

Chiltern International/ Sutro Biopharma

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology